As care delivery shifts toward emergency rooms, outpatient clinics, ambulatory settings, and bedside assessment, providers are prioritizing imaging tools that can be used immediately without relying on fixed radiology infrastructure. This is driving demand for the handheld ultrasound devices market because portable systems fit directly into point-of-care workflows, allowing clinicians to shorten triage time, support rapid decision-making, and assess patients in locations where full-sized ultrasound equipment is impractical. Procurement decisions increasingly favor compact devices that improve access to real-time imaging across decentralized care environments, supporting market development as ultrasound becomes a routine extension of frontline clinical examination.
Advancements in AI-enabled imaging and wireless ultrasound technologies improving diagnostic efficiency
Technology improvements are reshaping purchasing and usage patterns in the handheld ultrasound devices market by making compact systems easier to operate and faster to integrate into clinical routines. AI-enabled imaging helps automate image optimization, anatomical recognition, and workflow guidance, reducing dependence on highly specialized ultrasound expertise and influencing market adoption among broader groups of clinicians. Wireless connectivity removes cable constraints, simplifies device handling, and supports seamless transfer of scans into hospital networks, mobile platforms, and cloud-based review systems, reinforcing market demand from healthcare providers seeking faster diagnostics with less workflow friction.
Growing home healthcare and tele-ultrasound applications expanding handheld device utilization
The expansion of home-based care is creating new use cases for the handheld ultrasound devices market, particularly where patients require ongoing monitoring without frequent hospital visits. Compact form factors and simplified interfaces make handheld systems practical for community care teams, visiting clinicians, and remote assessment models, supporting market expansion as imaging moves closer to the patient. Tele-ultrasound workflows also increase utilization by enabling scans performed in decentralized settings to be reviewed or guided by off-site specialists, which helps providers extend diagnostic coverage into underserved locations while making handheld devices a more viable part of routine remote care delivery.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing point-of-care diagnostics adoption driving demand for portable ultrasound imaging systems | 2.00% | Moderate | Asia Pacific, North America | High | Near Term |
| Advancements in AI-enabled imaging and wireless ultrasound technologies improving diagnostic efficiency | 1.70% | Moderate | North America, Europe | High | Mid Term |
| Growing home healthcare and tele-ultrasound applications expanding handheld device utilization | 1.40% | Moderate | Asia Pacific, Latin America | Emerging | Long Term |
North America held the leading regional position in 2025, accounting for a 30.87% share of the handheld ultrasound devices market. This leadership is supported by broad adoption of point-of-care imaging across hospitals, emergency departments, outpatient settings, and physician practices, where portability and rapid bedside assessment fit established clinical workflows. The region’s market activity is also aided by strong purchasing capacity and a mature care delivery environment that supports faster integration of compact imaging tools into routine diagnostics and monitoring.
Asia Pacific is projected to expand at a 6.55% CAGR over the forecast period in the handheld ultrasound devices market, driven by rising adoption of portable diagnostic tools across a wider range of care settings. Growth is being accelerated by practical demand for accessible imaging in both urban and underserved areas, where handheld systems can extend ultrasound availability beyond traditional radiology infrastructure. As healthcare providers continue to prioritize mobility, faster examinations, and broader point-of-care use, adoption is increasing across everyday clinical practice in the region.
The U.S. handheld ultrasound devices market is advancing through greater adoption in emergency care, primary care, and outpatient settings. Healthcare providers in the U.S. are prioritizing portable imaging solutions with artificial intelligence support, wireless connectivity, and streamlined clinical workflows.
Japan is expanding the use of handheld ultrasound devices across aging care, community healthcare, and specialized medical services. Healthcare providers are focusing on compact imaging systems that deliver reliable diagnostics while supporting efficient patient assessment in diverse clinical environments.
South Korea is adopting handheld ultrasound devices that align with digitally connected healthcare infrastructure. Manufacturers are enhancing wireless functionality, cloud-enabled image management, and portable diagnostic capabilities to support faster clinical decision-making across hospitals and outpatient facilities.
Germany is incorporating handheld ultrasound devices into hospital and ambulatory care environments to improve diagnostic accessibility. Medical institutions are emphasizing image quality, secure data integration, and compatibility with digital healthcare systems to strengthen clinical efficiency across Germany.
France is integrating handheld ultrasound devices into emergency medicine, primary care, and rural healthcare delivery. Healthcare organizations are prioritizing portable imaging systems that improve patient access while maintaining diagnostic consistency and efficient workflow across clinical settings in France.
Italy is expanding handheld ultrasound device adoption to improve diagnostic flexibility across hospitals, clinics, and community healthcare services. Providers are investing in user-friendly portable imaging technologies that support timely examinations while reducing dependence on fixed diagnostic equipment.
Within the handheld ultrasound devices market, 3D/4D Ultrasound held a 49.49% share in 2025, reflecting its clear lead and continued expansion within the technology segment. Its position is backed by the practical value of richer real-time imaging in point-of-care settings, where clinicians increasingly need more detailed visualization without relying on larger cart-based systems. The same advantage is sustaining its growth momentum, as adoption in the handheld ultrasound devices market is being reinforced by rising preference for compact devices that can deliver higher diagnostic confidence in mobile, bedside, and rapid-assessment workflows.
End-use Segment Analysis: Hospitals (Largest Segment) vs Primary Clinics (Fastest-Growing Segment)
Hospitals accounted for a 44.62% share of the handheld ultrasound devices market in 2025, making them the leading end-use segment. Their leadership is rooted in the steady volume and breadth of imaging needs across emergency care, inpatient monitoring, critical care, and specialist departments, where handheld systems fit naturally into fast-paced clinical workflows. Hospitals also tend to absorb new imaging tools more readily because these devices improve bedside assessment efficiency while complementing existing diagnostic infrastructure in the handheld ultrasound devices market.
Primary Clinics are emerging as the fastest-growing end-use segment in the handheld ultrasound devices market as care delivery continues shifting toward earlier assessment and routine point-of-care evaluation outside large hospital environments. Growth is being influenced by the practical need for accessible imaging in frontline settings, where handheld systems help clinicians make quicker decisions without referring every case to centralized imaging departments. Compared with hospitals, primary clinics are gaining momentum because portable ultrasound directly expands diagnostic capability at the site of first patient contact.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Technology | 2D Ultrasound, 3D/4D Ultrasound, Doppler Ultrasound | 3D/4D Ultrasound | 3D/4D Ultrasound |
| End-use | Hospitals, Primary Clinics, Others | Hospitals | Primary Clinics |
| Application | Obstetrics/Gynecology, Cardiovascular, Urology, Gastroenterology, Musculoskeletal, Trauma, Others | Musculoskeletal | Trauma |
1. GE HealthCare (USA)
2. Koninklijke Philips N.V. (Netherlands)
3. Siemens Healthineers AG (Germany)
4. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
5. Samsung Medison Co. Ltd. (South Korea)
6. Butterfly Network Inc. (USA)
7. FUJIFILM Sonosite Inc. (USA)
8. Clarius Mobile Health Corp. (Canada)
9. CHISON Medical Technologies Co. Ltd. (China)
10. Terason (USA)
The handheld ultrasound devices market is experiencing strong momentum due to growing demand for portable and point-of-care diagnostic solutions. Advancements in wireless imaging, AI-assisted interpretation, and compact device engineering are improving accessibility across emergency care, primary healthcare, and remote medical settings. Expanding healthcare digitization initiatives and increasing emphasis on rapid diagnostics are also accelerating market penetration globally.
| Company Name | Date | Key Development |
|---|---|---|
| Clarius Mobile Health | Dec-25 | Clarius Mobile Health secured new FDA clearances for specialized AI-powered applications, including Prostate AI and Median Nerve AI. This regulatory achievement facilitates the expansion of the company’s handheld ultrasound portfolio and supports the scaling of its global distribution network, directly enhancing the diagnostic utility and commercial reach of its mobile imaging offerings. |
| Samsung Medison | May-25 | Samsung Medison formed a strategic partnership with Exo Imaging to co-develop next-generation ultrasound platforms incorporating advanced artificial intelligence. This collaboration aims to leverage integrated AI capabilities to significantly enhance clinical performance and device functionality, positioning both firms to compete more effectively within the evolving market for AI-augmented diagnostic imaging solutions. |
| HeartFocus | May-26 | HeartFocus launched the Link AI platform, designed to interface with existing hospital ultrasound systems to provide structured, AI-guided cardiac imaging training. By addressing specific clinician skill gaps through automated educational workflows, the platform enhances the accessibility and proficiency of cardiac ultrasound interpretation, facilitating broader adoption of high-quality imaging within diverse clinical environments. |
| GE HealthCare | Apr-24 | GE HealthCare integrated Caption AI functionality into its handheld ultrasound devices, offering real-time, step-by-step probe guidance and automated image quality assessment. This technological deployment lowers the barrier to entry for non-specialist clinicians, improving the acquisition of diagnostically accurate cardiac scans and expanding the utility of handheld ultrasound in point-of-care settings. |
| DESKi | Oct-24 | DESKi launched the HeartFocus cardiac ultrasound education application, integrated directly with Butterfly Network hardware. The initiative focuses on standardizing clinical training and enhancing scan quality through AI-driven feedback. This integration represents a significant ecosystem development, pairing specialized educational software with mobile hardware to improve clinical competency and the operational scalability of point-of-care ultrasound. |
| Clarius Mobile Health | Jan-24 | Clarius Mobile Health received CE Mark approval for its PAL HD3 wireless handheld ultrasound scanner. The device features a hybrid probe design, combining phased and linear arrays to support comprehensive whole-body imaging in a single unit. This approval strengthens the company’s competitive positioning in European and UK markets by enabling efficient, versatile bedside diagnostics. |
| GE HealthCare | Jan-25 | GE HealthCare received FDA 510(k) clearance for the Voluson Expert Series, which integrates advanced AI-powered workflow and imaging enhancement tools. This upgrade focuses on increasing clinical efficiency in women’s health diagnostics, representing a material advancement in the commercial application of automated features within the company’s ultrasound portfolio. |
| Butterfly Network | Oct-25 | Butterfly Network partnered with the University of Rochester Health Lab to develop MSK VUE, an AI-powered application for musculoskeletal ultrasound training. The platform utilizes interactive imaging to guide clinicians in identifying anatomical structures. This initiative expands the use of educational AI tools within the handheld ultrasound market, targeting improved clinical precision and expanded utility in orthopedic assessment. |